Key Takeaways TNDM reported a Q4 loss of 1 cent per share as revenues rose 15.1% to $290.4 million, beating estimates. Tandem Diabetes achieved record U.S. and international pump shipments, lifting gross margin to 57.7%. TNDM guided 2026 GAAP sales of $1.065B-$1.085B after posting $1.01B in 2025 non-GAAP revenues.Tandem Diabetes Care, Inc. (TNDM) posted a fourth-quarter 2025 loss of 1 cent per share compared with a loss of 44 cents a year ago. The figure surpassed the Zacks Consensus Estimate of a loss of 5 ...